Genetic basis of end-stage hypertrophic cardiomyopathy

European Journal of Heart Failure

Volumn 13, Issue 11, 2011, Pages 1193-1201

  Garcia Pavia, Pablo ^a,b   Vzquez, Maria E ^a   Segovia, Javier ^a,b   Salas, Clara ^a   Avellana, Patricia ^a   Gmez Bueno, Manuel ^a,b   Vilches, Carlos ^a   Gallardo, M Esther ^c   Garesse, Rafael ^c   Molano, Jess ^d   Bornstein, Beln ^a,c   Alonso Pulpon, Luis ^a,b  

^a HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^b Red Temtica de Investigacin en Insuficiencia Cardiaca   (Spain)

^c CSIC   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cardiac transplant; Heart failure; Hypertrophic cardiomyopathy; Mutations; Sarcomeric proteins

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FAMILY HISTORY; FEMALE; GENE; GENE MUTATION; GENETIC SCREENING; HEART TRANSPLANTATION; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LAMP2 GENE; MALE; MYBPC3 GENE; MYH7 GENE; MYL2 GENE; MYL3 GENE; PHENOTYPE; PRIORITY JOURNAL; SARCOMERE; TNNI3 GENE;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; GENOTYPE; HEART TRANSPLANTATION; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PREVALENCE;

EID: 80155172478     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr110     Document Type: Article

References (33)

1. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2008;29:270-276.
2. Maron BJ. Hypertrophic cardiomyopathy: A systematic review. JAMA 2002;287: 1308-1320.
3. Harris KM, Spirito P, Maron MS, Zenovich AG, Formisano F, Lesser JR, Mackey-Bojack S, Manning WJ, Udelson JE, Maron BJ. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006;114:216-225.
4. Melacini P, Basso C, Angelini A, Calore C, Bobbo F, Tokajuk B, Bellini N, Smaniotto G, Zucchetto M, Iliceto S, Thiene G, Maron BJ. Clinicopathological profiles of progressive heart failure in hypertrophic cardiomyopathy. Eur Heart J 2010;31:2111-2123.
5. Biagini E, Spirito P, Leone O, Picchio FM, Coccolo F, Ragni L, Lofiego C, Grigioni F, Potena L, Rocchi G, Bacchi-Reggiani L, Boriani G, Prandstraller D, Arbustini E, Branzi A, Rapezzi C. Heart transplantation in hypertrophic cardiomyopathy. Am J Cardiol 2008;101:387-392.
6. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C, Benaiche A, Isnard R, Dubourg O, Burban M, Gueffet JP, Millaire A, Desnos M, Schwartz K, Hainque B, Komajda M, EUROGENE Heart Failure Project. Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003;107:2227-2232.
7. Olivotto I, Girolami F, Ackerman MJ, Nistri S, Bos JM, Zachara E, Ommen SR, Theis JL, Vaubel RA, Re F, Armentano C, Poggesi C, Torricelli F, Cecchi F. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. Mayo Clin Proc 2008;83:630-638.
8. Morita H, Rehm HL, Menesses A, McDonough B, Roberts AE, Kucherlapati R, Towbin JA, Seidman JG, Seidman CE. Shared genetic causes of cardiac hypertrophy in children and adults. N Engl J Med 2008;358:1899-1908.
9. Girolami F, Ho CY, Semsarian C, Baldi M, Will ML, Baldini K, Torricelli F, Yeates L, Cecchi F, Ackerman MJ, Olivotto I. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. J Am Coll Cardiol 2010;55:1444-1453.
10. Kaski JP, Syrris P, Esteban MT, Jenkins S, Pantazis A, Deanfield JE, McKenna WJ, Elliott PM. Prevalence of sarcomere protein gene mutations in preadolescent children with hypertrophic cardiomyopathy. Circ Cardiovasc Genet 2009;2:436-441.
11. Arad M, Maron BJ, Gorham JM, Johnson WH Jr, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ, Seidman CE, Seidman JG. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med 2005;352: 362-372.
12. Theis JL, Bos JM, Bartleson VB, Will ML, Binder J, Vatta M, Towbin JA, Gersh BJ, Ommen SR, Ackerman MJ. Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. Biochem Biophys Res Commun 2006;351: 896-902.
13. Tsoutsman T, Kelly M, Ng DC, Tan JE, Tu E, Lam L, Bogoyevitch MA, Seidman CE, Seidman JG, Semsarian C. Severe heart failure and early mortality in a doublemutation mouse model of familial hypertrophic cardiomyopathy. Circulation 2008;117:1820-1831.
14. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. Eur Heart J 2003;24:1965-1991.
15. Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ. Hypertrophic cardiomyopathy: The interrelation of disarray, fibrosis, and small vessel disease. Heart 2000;84:476-482.
16. CardioGenomics Project Web site. The Program in Genomics Applications. Boston: NHLBI Program for Genomic Applications, Harvard Medical School. http ://cardiogenomics.med.harvard.edu (accessed 18 July 2010).
17. García-Pavía P, Segovia J, Molano J, Mora R, Kontny F, Erik Berge K, Leren TP, Alonso-Pulpón L. High-risk hypertrophic cardiomyopathy associated with a novel mutation in cardiac Myosin-binding protein C. Rev Esp Cardiol 2007;60: 311-314.
18. Landstrom AP, Ackerman MJ. Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy. Circulation 2010;122:2441-2450.
19. Saltzman AJ, Mancini-DiNardo D, Li C, Chung WK, Ho CY, Hurst S, Wynn J, Care M, Hamilton RM, Seidman GW, Gorham J, McDonough B, Sparks E, Seidman JG, Seidman CE, Rehm HL. Short communication: The cardiac myosin binding protein C Arg502Trp mutation: A common cause of hypertrophic cardiomyopathy. Circ Res 2010;106:1549-1552.
20. Havndrup O, Bundgaard H, Andersen PS, Allan Larsen L, Vuust J, Kjeldsen K, Christiansen M. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. Cardiovasc Res 2003;57:347-357.
21. Katzberg H, Karamchandani J, So YT, Vogel H, Wang CH. End-stage cardiac disease as an initial presentation of systemic myopathies: case series and literature review. J Child Neurol 2010;25:1382-1388.
22. Ho CY. Genetics and clinical destiny: Improving care in hypertrophic cardiomyopathy. Circulation 2010;122:2430-2440.
23. Kabaeva ZT, Perrot A, Wolter B, Dietz R, Cardim N, Correia JM, Schulte HD, Aldashev AA, Mirrakhimov MM, Osterziel KJ. Systematic analysis of the regulatory and essential myosin light chain genes: Genetic variants and mutations in hypertrophic cardiomyopathy. Eur J Hum Genet 2002;10:741-748.
24. Consevage MW, Salada GC, Baylen BG, Ladda RL, Rogan PK. A new missense mutation, Arg719Gln, in the beta-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy. Hum Mol Genet 1994;3:1025-1026.
25. García-Castro M, Coto E, Reguero JR, Berrazueta JR, Alvarez V, Alonso B, Sainz R, Martín M, Morís C. Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy. Rev Esp Cardiol 2009;62:48-56.
26. Laredo R, Monserrat L, Hermida-Prieto M, Fernández X, Rodríguez I, Cazón L, Alvariño I, Dumont C, Piñón P, Peteiro J, Bouzas B, Castro-Beiras A. Beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy. Rev Esp Cardiol 2006;59:1008-1018.
27. Rodríguez-García MI, Monserrat L, Ortiz M, Fernández X, Cazón L, Núñez L, Barriales-Villa R, Maneiro E, Veira E, Castro-Beiras A, Hermida-Prieto M. Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy. BMC Med Genet 2010;11:67.
28. Yacoub MH, Olivotto I, Cecchi F. 'End-stage' hypertrophic cardiomyopathy: From mystery to model. Nat Clin Pract Cardiovasc Med 2007;4:232-233.
29. Elliott P, Spirito P. Prevention of hypertrophic cardiomyopathy-related deaths: Theory and practice. Heart 2008;94:1269-1275.
30. Olivotto I, Maron MS, Adabag AS, Casey SA, Vargiu D, Link MS, Udelson JE, Cecchi F, Maron BJ. Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy. J Am Coll Cardiol 2005;46:480-487.
31. Monserrat L, Hermida M, Bouzas B, Mosquera I, Mahon N, Peteiro J, Alvarez N, Penas-Lado M, Crespo M, Castro-Beiras A. Familial dilated cardiomyopathy in patients transplanted for idiopathic dilated cardiomyopathy. Rev Esp Cardiol 2002;55:725-732.
32. Kärkkäinen S, Reissell E, Heliö T, Kaartinen M, Tuomainen P, Toivonen L, Kuusisto J, Kupari M, Nieminen MS, Laakso M, Peuhkurinen K. Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. Heart 2006;92:524-526.
33. Sokolow M, Lyon TP. The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949;38:273-294.